The global Impingement Syndrome Market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Impingement syndrome is a shoulder condition that occurs when soft tissues are squeezed or “pinched” between two bones. Common treatment options include physiotherapy, medication, activity modification, injections, and surgery if conservative treatments fail. Physiotherapy focuses on restoring shoulder mobility and strengthening muscles to reduce stress.
Market key trends:
Increasing popularity of non-surgical treatment options is one of the key trends fueling market growth. Physiotherapy is becoming a preferred first line of treatment for impingement syndrome due to benefits such as being non-invasive and helping to relieve pain and improve joint movement in a few weeks. It focuses on different techniques including stretching, range of motion exercises and strengthening exercises. Various physiotherapy treatments like ice therapy, thermal therapy, electrotherapy, manual therapy, and therapeutic exercises aid in pain management and rehabilitate the shoulder effectively.
The global Impingement Syndrome Market Size is dominated by shoulder impingement, which accounts for over 70% of the market share. This is due to the high prevalence of shoulder impingement, which is caused due to repetitive overhead motions and weak rotator cuff muscles. Shoulder impingement causes shoulder pain and limited range of motion and is commonly seen among athletes and individuals involved in overhead activities.
The global impingement syndrome market is expected to witness high growth, exhibiting a CAGR of 7.5% over the forecast period, due to increasing geriatric population. The elderly are more prone to orthopedic diseases like impingement syndrome due to osteoporosis and weak muscles.
North America dominates the global impingement syndrome market with over 40% share owing to advanced healthcare facilities and rising healthcare spending in the region. Additionally, presence of major players and rapid adoption of novel treatments for impingement are driving the North American market. Asia Pacific is expected to exhibit the fastest growth over the forecast period attributed to large patient pool and improving access to healthcare in developing countries.
Key players operating in the impingement syndrome market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., DJO Global, Inc., Ã–ssur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., Bioventus LLC. The major players are focusing on new product launches and geographic expansion to gain higher market shares.
Read Our More Blogs : https://www.rapidwebwire.com/impingement-syndrome-market-size-share-analysis-2023-2030/